SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993; 30: 672679.
  • 2
    Provencher SW. A constrained regularization method for inverting data represented by linear algebraic or integral equations. Comput. Phys. Commun. 1982; 27: 213227.
  • 3
    Schirmer T, Auer DP. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed. 2000; 13: 2836.
  • 4
    Provencher SW, Hänicke W, Michaelis T. Automated quantitation of localized 1H MR spectra in vivo: capabilities and limitations. 3rd Scientific Meeting of the Society of Magnetic Resonance, Abstracts, 1995; 1952.
  • 5
    Nagatomo Y, Wick M, Prielmeier F, Frahm J. Dynamic monitoring of cerebral metabolites during and after transient global ischemia in rats by quantitative proton NMR spectroscopy in vivo. NMR Biomed. 1995; 8: 265270.
  • 6
    Frahm J, Krüger G, Merboldt K-D, Kleinschmidt A. Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man. Magn. Reson. Med. 1996; 35: 143148.
  • 7
    Pfeuffer J, Tkác̆ I, Provencher SW, Gruetter R. Towards an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time 1H NMR spectra of the rat brain. J. Magn. Reson. 1999; 141: 104120.
  • 8
    Helms G. Analysis of 1.5 Tesla proton MR spectra of human brain using LCModel and an imported basis set. Magn. Reson. Imag. 1999; 17: 12111218.
  • 9
    Provencher SW. Automated estimation of metabolite concentrations from localized proton MRS. In New Prospects in Psychiatry. The Bio-clinical Interface, MacherJ-P, CrocqM-A, NedelecJ-F (eds). John Libbey: Paris, 1995; 405413.
  • 10
    Hofmann L, Slotboom J, Boesch C, Kreis R. Model fitting of 1H-MR spectra of the human brain: incorporation of short-T1 components and evaluation of parameterized vs. non-parameterized models. 7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Abstracts, 1999; 586.
  • 11
    Provencher SW. Automated quantitation of localized 1H MR spectra in vivo at short echo times with baseline distortion. 5th Scientific Meeting of the International Society of Magnetic Resonance in Medicine Abstracts, 1997; 1411.
  • 12
    Sailasuta N, Hurd RE, Provencher S. Automated prior knowledge fitting of over-sampled J-resolved spectra. 6th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Abstracts, 1998; 1842.
  • 13
    Cady EB, D'Souza PC. Analysis of proton brain spectra from human infants by fitting linear combinations of model spectra. J. Magn. Reson. Anal. 1997; 3: 514.
  • 14
    Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of brain disorders in childhood. In Advances in Neurochemistry, BachelardH (ed.), Vol. 8: Plenum Press: New York, 1997; 329402.
  • 15
    Woermann FG, McLean MA, Bartlett PA, Parker GJ, Barker GJ, Duncan JS. Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann. Neurol. 1999; 45: 369376.
  • 16
    McLean MA, Parker GJM, Barker GJ. Automated production of quantitative metabolite maps from short echo time 1H-CSI of the brain. 6th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Abstracts, 1998; 626.
  • 17
    Wang Y, Yang B, Ng TC. Differences of metabolites in mesial and lateral temporal lobes. 7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Abstracts, 1999; 1429.
  • 18
    Pouwels PJW, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn. Reson. Med. 1998; 39: 5360.
  • 19
    Pouwels PJW, Brockmann K, Kruse B, Wilken B, Wick M, Hanefeld F, Frahm J. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr. Res. 1999; 46: 474485.
  • 20
    Choi CG, Frahm J. Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn. Reson. Med. 1999; 41: 204207.
  • 21
    Thiel T, Panow C, Hennig J, Martin E. Metabolic asymmetries as an early indicator for temporal lobe epilepsy in children. A comparison with EEG and high resolution MRI. 7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Abstracts, 1999; 1473.
  • 22
    Savic I, Lekvall Å, Greitz D, Helms G. MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy. Epilepsia 2000; 41: 290296.
  • 23
    Brex PA, Gomez-Anson B, Parker GJM, Molyneux PD, Miszkiel KA, Barker GJ, MacManus DG, Davie CA, Plant GT, Miller DH. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J. Neurol. Sci. 1999; 166: 1622.
  • 24
    van Walderveen MAA, Barkhof F, Pouwels PJW, van Schijndel RA, Polman CH, Castelijns JA. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann. Neurol 1999; 46: 7987.
  • 25
    Helms G, Stawiarz L, Kivisäkk P, Link H. Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions. Magn. Reson. Med. 2000; 43: 102110.
  • 26
    Speck O, Thiel T, Hennig J. Grading and therapy monitoring of astrocytomas with 1H-spectroscopy: preliminary study. Anticancer Res. 1996; 16: 15811586.
  • 27
    Wilken B, Helms G, Christen HJ, Behnke J, Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of a cerebellar tumor in a two-year-old child. Child's Nerv. Syst 1996; 12: 626629.
  • 28
    Chong VFH, Rumpel H, Aw Y-S, Ho G-L, Fan Y-F, Chua E-J. Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings. Int J. Radiat. Oncol. Biol. Phys. 1999; 45: 699705.
  • 29
    Rose SE, de Zubicaray GI, Wang D, Galloway GJ, Chalk JB, Eagle SC, Semple J, Doddrell DM. A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn. Reson. Imag. 1999; 17: 291299.
  • 30
    Stöckler S, Hanefeld F, Frahm J. Creatine replacement therapy in guanidinoacetate methyltranferase deficiency, a novel inborn error of metabolism. Lancet 1996; 348: 789790.
  • 31
    Ebert D, Speck O, König A, Berger M, Hennig J, Hohagen F. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiat. Res. Neuroimag. 1997; 74: 173176.
  • 32
    Pioro EP, Majors AW, Mitsumoto H, Nelson DR, Ng TC. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 1999; 53: 7179.
  • 33
    Rubio-Gozalbo ME, Heerschap A, Trijbels JMF, De Meirleir L, Thijssen HOM, Smeitink JAM. Proton MR spectroscopy in a child with pyruvate dehydrogenase complex deficiency. Magn. Reson. Imag. 1999; 17: 939944.
  • 34
    Wilichowski E, Pouwels PJW, Frahm J, Hanefeld F. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS. Neuropediatrics 1999; 30: 256263.
  • 35
    Kraft E, Trenkwalder C, Then Bergh F, Auer DP. Magnetic resonance proton spectroscopy of the brain in Wilson's disease. J. Neurol. 1999; 246: 693699.
  • 36
    van der Knaap MS, Wevers RA, Struys EA, Verhoeven NM, Pouwels PJW, Engelke UFH, Feikema W, Valk J, Jakobs C. Leukoencephalopathy associated with a disturbance in the metabolism of polyols. Ann. Neurol. 1999; 46: 925928.
  • 37
    Rose SE, Chalk JB, Galloway GJ, Doddrell DM. Detection of dimethyl sulfone in the human brain by in vivo proton magnetic resonance spectroscopy. Magn. Reson. Imag. 2000; 18: 9598.